Study provides safety and performance confidence for MED-EL's TICI

The Austrian med-tech company specialising in cochlear implants (CI), MED-EL, has welcomed the results of a feasibility study on the Totally Implantable CI (TICI) it has developed and now successfully delivered in surgical procedures. TICI is still in research and not yet available commercially, but results published in the January 2025 issue of the journal Communications Medicine suggest high levels of hearing performance for the innovative implant, "comparable to those of a conventional CI". But the primary purpose of the study was to assess TICI's safety, which was also found to be comparable to that of conventional CIs.   Academics from Belgium and Germany assessed the safety of TICI   The study took place at the University Hospital Center of Liège, Belgium, and the...